Renal cell carcinoma with fibromyomatous stroma associated with TSC/MTOR alterations and ELOC (TCEB1) mutations differ in mTOR activation status assessed by immunohistochemistry Meeting Abstract

  

Authors:	Chen, J. F.; Jia, L.; Gandhi, J.; Sarungbam, J.; Sirintrapun, S. J.; Gopalan, A.; Al-Ahmadie, H.; Fine, S.; Hakimi, A.; Tickoo, S.; Reuter, V.; Chen, Y. B.
Abstract Title:	Renal cell carcinoma with fibromyomatous stroma associated with TSC/MTOR alterations and ELOC (TCEB1) mutations differ in mTOR activation status assessed by immunohistochemistry
Meeting Title:	110th Annual Meeting of the United States & Canadian Academy of Pathology (USCAP)
Journal Title:	Modern Pathology
Volume:	34
Issue:	Suppl. 2
Meeting Dates:	2022 Mar 13-18
Meeting Location:	Virtual
ISSN:	0893-3952
Publisher:	Nature Research
Date Published:	2021-03-01
Start Page:	547
End Page:	548
Language:	English
ACCESSION:	WOS:000629690900447
PROVIDER:	wos
PUBMED:	33707681
DOI:	10.1038/s41379-021-00760-7
Notes:	Meeting Abstract: 446 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/181110